Open Access: Differential modulation of allergic rhinitis nasal transcriptome by dupilumab and allergy immunotherapy. First and corresponding author: Matthew F. Wipperman; corresponding authors: Jennifer Hamilton and Meagan P. O'Brien
Read the article here:
doi.org/10.1111/all.16001
This study aimed to understand the pathobiology of allergic rhinitis (AR) by analysing transcriptome data from nasal brushing samples of individuals with and without AR, and those undergoing different treatments. The study evaluated how treatments, including
#dupilumab, subcutaneous immunotherapy (SCIT), and a combination of both, versus placebo, influenced AR and allergen challenge specific gene signatures in nasal tissue. Results showed that both dupilumab and SCIT dupilumab significantly repressed the AR disease signature, and all three treatments repressed the nasal allergen challenge (NAC) gene signature.
#Allergy_journal @junkRNA
Read more articles published in
#Allergy on
#rhinitis here:
journalallergy.com/Rhinitis-…